Molecular Pathology in Vulnerable Carotid Plaques: Correlation with [18]-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

European Journal of Vascular and Endovascular Surgery

Volumn 37, Issue 6, 2009, Pages 714-721

  Graebe M ^a   Pedersen, S F ^a   Borgwardt, L ^b   Hojgaard L ^b   Sillesen, H ^a   Kjaer A ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

18 Fluorodeoxyglucose (FDG); Carotid artery plaque; Gene expression; Positron emission tomography (PET); Stroke

Indexed keywords

CATHEPSIN K; CD68 ANTIGEN; FLUORODEOXYGLUCOSE F 18; GELATINASE B; INTERLEUKIN 18; MESSENGER RNA;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE ASSOCIATION; DRUG UPTAKE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL PATIENT; TRANSIENT ISCHEMIC ATTACK; UPREGULATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CAROTID STENOSIS; CATHEPSINS; ENDARTERECTOMY, CAROTID; FEMALE; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-18; ISCHEMIC ATTACK, TRANSIENT; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67349252062     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2008.11.018     Document Type: Article

References (41)

1. Rothwell P.M., Giles M.F., Chandratheva A., Marquardt L., Geraghty O., Redgrave J.N., et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (express study): a prospective population-based sequential comparison. Lancet 370 (2007) 1432-1442
2. Ois A., Gomis M., Rodriguez-Campello A., Cuadrado-Godia E., Jimenez-Conde J., Pont-Sunyer C., et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke 39 (2008) 1717-1721
3. Fairhead J.F., Mehta Z., and Rothwell P.M. Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 65 (2005) 371-375
4. Coull A.J., Lovett J.K., and Rothwell P.M. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: Implications for public education and organisation of services. BMJ 328 (2004) 326
5. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North american symptomatic carotid endarterectomy trial collaborators. N Engl J Med 325 (1991) 445-453
6. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery trial (ecst). Lancet 351 (1998) 1379-1387
7. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
8. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108 (2003) 1664-1672
9. Schwartz S.M., Galis Z.S., Rosenfeld M.E., and Falk E. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 27 (2007) 705-713
10. Papaspyridonos M., Smith A., Burnand K.G., Taylor P., Padayachee S., Suckling K.E., et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 26 (2006) 1837-1844
11. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104 (2001) 1598-1603
12. Sillesen H. What does 'best medical therapy' really mean?. Eur J Vasc Endovasc Surg 35 (2008) 139-144
13. Packard R.R., and Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54 (2008) 24-38
14. Weissberg P.L. Noninvasive imaging of atherosclerosis: the biology behind the pictures. J Nucl Med 45 (2004) 1794-1795
15. Tang T.Y., Moustafa R.R., Howarth S.P., Walsh S.R., Boyle J.R., Li Z.Y., et al. Combined PET-FDG and uspio-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis. Eur J Vasc Endovasc Surg 36 (2008) 53-55
16. Bural G.G., Torigian D.A., Chamroonrat W., Houseni M., Chen W., Basu S., et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35 (2008) 562-569
17. Yun M., Jang S., Cucchiara A., Newberg A.B., and Alavi A. 18f FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 32 (2002) 70-76
18. Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., and Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26 (2001) 314-319
19. Bural G.G., Torigian D.A., Chamroonrat W., Alkhawaldeh K., Houseni M., El-Haddad G., et al. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. Nucl Med Biol 33 (2006) 1037-1043
20. Rudd J.H.F., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., et al. Imaging atherosclerotic plaque inflammation with [18f]-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
21. Tawakol A., Migrino R.Q., Bashian G.G., Bedri S., Vermylen D., Cury R.C., et al. In vivo 18f-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48 (2006) 1818-1824
22. Nold M., Goede A., Eberhardt W., Pfeilschifter J., and Muhl H. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10. Naunyn Schmiedebergs Arch Pharmacol 367 (2003) 68-75
23. Sukhova G.K., Shi G.P., Simon D.I., Chapman H.A., and Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102 (1998) 576-583
24. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273 (1998) 32347-32352
25. Jaffer F.A., Kim D.E., Quinti L., Tung C.H., Aikawa E., Pande A.N., et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation 115 (2007) 2292-2298
26. Polak J.F. Carotid ultrasound. Radiol Clin North Am 39 (2001) 569-589
27. Rudd J.H., Myers K.S., Bansilal S., Machac J., Pinto C.A., Tong C., et al. Atherosclerosis inflammation imaging with 18f-FDG-PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 49 (2008) 871-878
28. Rudd J.H., Myers K.S., Bansilal S., Machac J., Rafique A., Farkouh M., et al. (18)fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 50 (2007) 892-896
29. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel iii guidelines. Circulation 110 (2004) 227-239
30. Holness C.L., and Simmons D.L. Molecular cloning of cd68, a human macrophage marker related to lysosomal glycoproteins. Blood 81 (1993) 1607-1613
31. Yamagami H., Kitagawa K., Hoshi T., Furukado S., Hougaku H., Nagai Y., et al. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol 25 (2005) 1458-1462
32. Chapman C.M.L., McQuillan B.M., Beilby J.P., Thompson P.L., and Hung J. Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population: the Perth carotid ultrasound disease assessment study (cudas). Atherosclerosis 189 (2006) 414-419
33. Blankenberg S., Tiret L., Bickel C., Peetz D., Cambien F., Meyer J., et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106 (2002) 24-30
34. Lutgens S.P.M., Cleutjens K.B.J.M., Daemen M.J.A.P., and Heeneman S. Cathepsin cysteine proteases in cardiovascular disease. FASEB J 21 (2007) 3029-3041
35. Choudhary S., Higgins C.L., Chen I.Y., Reardon M., Lawrie G., Vick III G.W., et al. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 26 (2006) 2351-2358
36. Opdenakker G., Van den Steen P.E., and Van Damme J. Gelatinase b: a tuner and amplifier of immune functions. Trends Immunol 22 (2001) 571-579
37. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 92 (1995) 402-406
38. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
39. Gough P.J., Gomez I.G., Wille P.T., and Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoe-deficient mice. J Clin Invest 116 (2006) 59-69
40. Kai H., Ikeda H., Yasukawa H., Kai M., Seki Y., Kuwahara F., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32 (1998) 368-372
41. Eldrup N., Gronholdt M.-L.M., Sillesen H., and Nordestgaard B.G. Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis. Circulation 114 (2006) 1847-1854